Results 131 to 140 of about 1,397,977 (265)

Single‐cell DNA methylation profiling: Technologies, computation, and applications in precision oncology

Molecular Oncology, EarlyView.
Single‐cell DNA methylation (scDNAme) profiling maps epimutational clonal evolution, revealing mechanisms of malignancy and therapeutic resistance across diverse cancer types. By providing a high‐resolution landscape of intratumoral heterogeneity, these technologies empower precise patient stratification, guide the development of enhanced ...
Ik Soo Kim
wiley   +1 more source

Microbe-induced resistance involves priming of direct or indirect defenses according to the stage of herbivory. [PDF]

New Phytol
Rivero J, Fernández I, Colina FJ, Touw AJ, Weinhold A, Rodríguez-Blanco PM, Kester K, Pozo MJ, van Dam NM, Martínez-Medina A.   +9 more
europepmc   +1 more source

Attempts to Induce Resistance to Cancer

Annals of Surgery, 1955
H B, STONE, L, SCHNAUFER
openaire   +3 more sources

Targeting transcription factors associated with hemoglobinopathies: Lessons from successful interventions and implications for cancer

Molecular Oncology, EarlyView.
This review summarizes the transcription factors, repressive chromatin‐modifying complexes, and epigenetic mechanisms that control fetal hemoglobin repression. Notably, many regulators of γ‐globin silencing also function in transcriptional and epigenetic networks that drive cancer, highlighting opportunities to translate advances in hemoglobinopathy ...
Meigen Yu, Puspa Das, Xing Zhang, Xiaodong Cheng   +3 more
wiley   +1 more source

Microbial-mediated induced resistance: interactive effects for improving crop health. [PDF]

Front Microbiol
Charpe AM, Aglave B, Ghosh DK.
europepmc   +1 more source

CAN RESISTANCE TO CANCER BE INDUCED?*

Annals of Surgery, 1951
H B, STONE, R M, CURTIS, J H, BREWER
openaire   +3 more sources

Interferon beta drives therapy resistance in a patient‐derived model of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Interferon type 1 (IFN‐1) production and signaling is associated with the acquisition of therapy resistance, following chronic DNA damage, via Interferon‐related DNA damage resistance signature (IRDS) gene expression. An alternative, DNA damage‐independent role of sustained IFN‐1 mediated resistance was identified and characterized by the emergence of ...
Ashlyn Conant, Tise Suzuki, Kiera McGivney, V. S. S. Abhinav Ayyadevara, Sharon Asariah, Jay Deng, Ethan Nyein, Jacqueline Coats, Gary Yu, Yevgeniya J. Ioffe, Christian Hurtz, Juli J. Unternaehrer   +11 more
wiley   +1 more source

ERRATUM: Hyperglycaemia-induced resistance to Docetaxel is negated by metformin: a role for IGFBP-2. [PDF]

Endocr Relat Cancer
Biernacka KM, Persad RA, Bahl A, Gillatt D, Holly JMP, Perks CM.   +5 more
europepmc   +1 more source

CEACAM1 participation in breast cancer progression

Molecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin, Irina Kube‐Golovin, Anatolii Romaniuk, Gunther Wennemuth   +3 more
wiley   +1 more source

Arabidopsis phospholipid modifications mediate cellulase-induced resistance to a fungal peptide antibiotic by imposing cell polarity. [PDF]

New Phytol
Panthapulakkal Narayanan S, Dotson BR, Noack L, Holla S, Ren S, Dörmann P, Widell S, Persson S, Lager I, Rasmusson AG.   +9 more
europepmc   +1 more source